C4 Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $15,362 | $12,006 | $3,039 | $3,261 |
Gross Profit | 13,306 | 9,961 | 1,012 | 1,570 |
EBITDA | -22,610 | -15,671 | -26,334 | -32,786 |
EBIT | -24,666 | -17,716 | -28,361 | -34,477 |
Net Income | -24,666 | -17,716 | -28,361 | -34,754 |
Net Change In Cash | 15,362 | 12,006 | 3,039 | 3,261 |
Free Cash Flow | -24,120 | -5,171 | -18,118 | -24,166 |
Cash | 59,649 | 73,114 | 89,659 | 126,590 |
Basic Shares | 69,627 | 68,810 | 68,432 | 51,216 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $20,756 | $31,096 | $45,785 | $33,195 |
Gross Profit | -96,950 | 23,524 | 42,878 | -44,273 |
EBITDA | -122,103 | -124,283 | -78,840 | -62,891 |
EBIT | -129,840 | -131,855 | -81,747 | -65,732 |
Net Income | -132,493 | -126,499 | -86,037 | -66,335 |
Net Change In Cash | 20,756 | 31,096 | 45,785 | 33,195 |
Cost of Revenue | -46,370 | -104,901 | 91,178 | |
Free Cash Flow | -108,546 | -111,435 | -88,242 | -67,899 |
Cash | 126,590 | 29,754 | 76,124 | 181,727 |
Basic Shares | 49,640 | 48,861 | 46,041 | 43,059 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.35 |
2024-06-30 | -$0.26 |
2024-03-31 | -$0.41 |
2023-12-31 | -$0.70 |
